Skip to content
Menu

Gelteq Limited GELS

Full chart Compare
Set alert

Price alert · GELS

All alert types
0.28 USD +0.01 (+3.93%)

As ofNov 19, 2026, 3:59 PM EST

0.28 Day range 0.2998
0.26 52-week range 2.01
YTD
-64.93%
1 year
-69.23%

5D -0.1350 (-32.93%)

0.25000.30000.35000.4000ThuFriMonTueWed0.2750
Market cap
3.23M
Revenue (ttm)
131.76K
EPS (ttm)
-0.44
Shares out
9.44M
YTD return
-64.93%
1-year return
-69.23%
Volume
10.87K
Avg volume
2.85M
Open
0.29
Previous close
0.27
Day's range
0.28 – 0.2998
52-week range
0.26 – 2.01

Key statistics

50-day average
2.45
200-day average
2.45
Enterprise value
15.48M
Price / sales
174.07
Price / book
1.21
Revenue growth
-68.90%
Free cash flow
-463.50K
Total cash
399.22K
Total debt
2.49M
Return on equity
-18.75%

Fundamental scorecard

1 of 25 checks passed on GELS’s reported financials

ValueGrowthProfitabilityHealthDividend

1of 25 checks passed

  • Value 0 of 5
  • Growth 0 of 5
  • Profitability 0 of 5
  • Financial health 1 of 5
  • Dividend 0 of 5

Statements to Jun 30, 2026.

Financials — quick view

All financials
GELS Revenue — quarterly 0
GELS Net income — quarterly -1.13M

About Gelteq Limited

Gelteq Limited focuses on developing and commercializing a gel-based delivery system for humans and animals. It offers white label gel-based delivery solutions for prescription drugs, over-the-counter products, nutraceuticals and sports, pet care, and other products. The company was incorporated in 2017 and is headquartered in Caulfield, Australia.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
Australia
Website
gelteq.com

News

Your note

Sign in to keep a note on GELS — it syncs with the Stock Master app.